Free shipping on all orders over $ 500

Vinflunine

Cat. No. M3723
Vinflunine Structure
Size Price Availability
5mg USD 140  USD140 Out of stock
10mg USD 260  USD260 Out of stock
50mg USD 795  USD795 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

The behavior of vinflunine in routine clinical practice resembles that of the pivotal phase III randomized study. Vinflunine(VFL)-EPR combination is feasible with manageable toxicity. The antitumour activity was promising and supports further evaluation. It underscores a critical function for VFL in cell-cell adhesions of epithelial bladder tumour cells, suggesting a novel molecular mechanism by which VFL may impact upon EMT and metastasis.

Chemical Information
Molecular Weight 816.93
Formula C45H54F2N4O8
CAS Number 162652-95-1
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Castellano D, et al. BMC Cancer. Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.

[2] Aparicio LA, et al. BMC Cancer. Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells.

[3] Chan S, et al. Cancer Chemother Pharmacol. A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer.

Related Microtubule Products
P34cdc2 Kinase Fragment

P34cdc2 Kinase Fragment is associated with the completion of DNA replication in yeast mitosis.

Cemadotin

Cemadotin (LU103793) is an analogue of Dolastatin 15 which is naturally occurring cytotoxic peptides.

VLS-1488

VLS-1488 is an orally active KIF18A inhibitor that inhibits KIF18A microtubule-dependent ATPase activity with an IC50 value of 0.016 μM.

ENMD-1198

ENMD-1198 (IRC-110160), an orally active microtubule destabilizing agent, is a 2-methoxyestradiol analogue with antiproliferative and antiangiogenic activity.

Tubulin/JAK2-IN-1

Tubulin/JAK2-IN-1 is a dual inhibitor of Janus kinase 2 (JAK2) and microtubule.

  Catalog
Abmole Inhibitor Catalog




Keywords: Vinflunine supplier, Microtubule, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.